SARS-CoV-2 immunity and HIV infection: total recall?

Lancet HIV. 2021 Jun;8(6):e312-e313. doi: 10.1016/S2352-3018(21)00097-7. Epub 2021 Apr 29.

Authors

Nicolas Dauby¹, Charlotte Martin²

Affiliations

¹ Department of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles, 1000 Brussels, Belgium; School of Public Health, Université Libre de Bruxelles, 1000 Brussels, Belgium; Institute for Medical Immunology, Université Libre de Bruxelles, 1000 Brussels, Belgium. Electronic address: [email protected].
² Department of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles, 1000 Brussels, Belgium.

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Neutralizing
COVID-19*
HIV Infections*
Humans
Immunoglobulin G
SARS-CoV-2
Seroepidemiologic Studies

Substances

Antibodies, Neutralizing
Immunoglobulin G